Arcus Biosciences, Inc. — Director's Dealing 2021

Feb 4, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Arcus Biosciences, Inc. (RCUS)
CIK: 0001724521
Period of Report: 2021-02-01

Reporting Person: ROSEN TERRY J (Director, Chief Executive Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-02-01	Common Stock	G	311900	$0.00	Disposed	0	Indirect

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	189393	Direct
Common Stock	3370940	Indirect
Common Stock	384004	Indirect

Footnotes

F1: 311,900 shares were transferred to various family trusts in which the reporting person has no pecuniary interest, but retains voting and dispositive power over all of the shares transferred to each trust. The remaining 86,450 shares were transferred into the Rosen Family Trust in a transaction exempt from Section 16 reporting pursuant to Rule 16a13.

F2: 86,450 and 53,311 shares previously held by the reporting person in Rosen GRAT No. 1 and No. 2, respectively, were transferred into the Rosen Family Trust in a transaction exempt from Section 16 reporting pursuant to Rule 16a13.

F3: 53,311 shares were transferred into the Rosen Family Trust in a transaction exempt from Section 16 reporting pursuant to Rule 16a13.